Stay updated with breaking news from Quality Assistance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In this interview, Arnaud Delobel, the R&D and Innovation Director at Quality Assistance talks to NewsMed-LS about the emerging field of gene therapy with adeno-associated viruses (AAV).
In this interview, Arnaud Delobel, the R&D and Innovation Director at Quality Assistance talks to AZoM about the emerging field of gene therapy with adeno-associated viruses (AAV).
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform Closing on € 30 million, AstriVax has raised the largest amount of...